MedTrace Logo

Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain

NCT04239976 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2022-03-24

No results posted yet for this study

Summary

This trial studies how well scrambler therapy works in reducing chemotherapy-induced neuropathic pain in patients with cancer. Scrambler therapy is a type of treatment that uses electrodes placed on the skin. Electricity is carried from the electrodes through the skin and blocks the pain.

Conditions

  • Chemotherapy-Induced Peripheral Neuropathy
  • Malignant Neoplasm

Interventions

DEVICE

FitBit

Wear FitBit for gait assessment test

OTHER

Gait Assessment Test

Undergo gait assessment test

OTHER

MC5-A Scrambler Therapy

Undergo scrambler therapy

OTHER

Quality-of-Life Assessment

Ancillary studies

PROCEDURE

Quantitative Sensory Testing

Undergo quantitative sensory test

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Salahadin Abdi · M.D. Anderson Cancer Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-04
Primary Completion
2022-03-18
Completion
2022-03-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04239976 on ClinicalTrials.gov